Open access peer-reviewed chapter

Medicinal Potential of Camel Milk Lactoferrin

Written By

Neelam Mahala, Aastha Mittal and Uma S. Dubey

Submitted: 17 September 2022 Reviewed: 27 September 2022 Published: 07 November 2022

DOI: 10.5772/intechopen.108316

From the Edited Volume

Current Issues and Advances in the Dairy Industry

Edited by Salam A. Ibrahim

Chapter metrics overview

153 Chapter Downloads

View Full Metrics

Abstract

Camel milk is a rich source of protein with well-recognized medicinal properties to treat various diseases. The objective of this work is to understand the role of camel milk lactoferrin in immunomodulation and in disease treatment. It has been found that camel milk lactoferrin is a very suitable nutraceutical agent by virtue of its bioactivity, immuno-compatibility, and safety. It can be used for the treatment of infectious, metabolic, and neurodegenerative diseases, besides cancer. It is a cost-effective biomolecule that also has high relative abundance and bioavailability.

Keywords

  • camel milk
  • lactoferrin
  • medicinal potential
  • commercial significance
  • immunomodulatory
  • anti-microbial
  • anti-cancer

1. Introduction

The medicinal properties of camel milk have long been recognized, especially in middle eastern countries. Camel Milk is a rich source of active proteins, especially enzymes that have several biological activities including antibacterial, antiviral, immunological, and antioxidant properties. Camel milk has been used to treat many diseases such as Hepatitis, Allergy, Liver, and kidney function, Diarrhea, and Diabetes. Moreover, camel milk has no allergenic properties and can be consumed by lactase-deficient people. Like human milk, camel milk has a high content of lactoferrin and α-lactalbumin but lacks β-lactoglobulin [1]. It differs from cow milk as it has lower fat, cholesterol, and lactose levels, besides this, there is an absence of beta-lactoglobulin and beta-casein. Beta casein is the allergenic component that is present in cow milk but absent in camel milk. Also, it has very low levels of lactose making it consumable by lactase deficient people [2]. It has been noted that despite the lack of refrigeration, camel’s milk remains unspoiled for several days. This may be due to the antibacterial activity of certain proteins contained in camel’s milk [3]. Furthermore, camel milk proteins are generally pH hydrolysis resistant and thermostable. Lactoferrin is well recognized as an adjunct to anti-cancer standard therapy by virtue of its immunomodulatory activity. It also exhibits immuno-compatibility, bioavailability, safety, relative abundance, and low-cost effectiveness. Moreover, the oral route of administration makes it very easy to be given to patients and it is usually well-tolerated [4]. Numerous studies on camel lactoferrin reported that it has anti-bacterial, anti-fungal, anti-viral, anti-inflammatory, antioxidant, and anti-tumor properties. Camel milk lactoferrin is a molecule that not only boosts the immune system but also acts against cancer. The objective of this work is to understand the role of camel milk lactoferrin in immunomodulation and in disease treatment [5].

Advertisement

2. Camel milk

Camel milk has been found to be a healthier option for people with diabetes and those with food allergies. Several studies on camel milk have found its positive impact on autism, diabetes, liver disease, jaundice, and even cancer. Camel milk is high in vitamin C, many minerals, and immunoglobulins, which boost the immune system. It is not only a very nutritious dairy beverage but it also innately includes probiotics. Camel milk helps enhance gastrointestinal health besides improving systemic immunity. The drink has a low-fat content (only 2 to 3%, compared to cow milk) and thus is likely to attract more attention of health-aware consumers. In various Middle East countries and an Africa, it is used as a suitable supplement to feed undernourished children because it’s similarity with human breast milk [6].

2.1 Medicinal properties of camel milk

Naturally occurring bioactive compounds have contributed effectively to cancer therapeutics, paving a way for better disease management. Camel milk is one such dietary food with immense nutritional and medicinal value. Like human and bovine milk, camel milk also contains numerous proteins such as immunoglobulins, alpha-lactalbumin, lactoperoxidase, casein, lysozyme, lactoferrin, amylase, etc. The major proteins present in camel milk along with their clinical significance have been depicted in Table 1. It forms a high nutritional source with low cholesterol, low sugar, high minerals (sodium, potassium, iron, copper, zinc, and magnesium), high vitamins (vitamin C, B2, A, and E), and high concentrations of insulin compared to the ruminant milk [20, 21, 22]. Moreover, very recently camel milk casein-derived nanoparticles have been used as carriers for the delivery of sorafenib in hepatocarcinoma cells [23].

S. NoClinical conditionTherapeutic molecules in camel milkReference
1DiabetesInsulin-like molecule[7]
2AllergyLow levels of β-Casein & lack of β-lactoglobulin[8]
3Liver and kidney functionAlanine aminotransferase and aspartate aminotransferase[9]
4Slimming propertiesLow protein content and reasonable cholesterol content[10]
5Antitumor activityLactoferrin, Lysozyme, Lactoperoxidase[11, 12]
6Nutritional supplementsUnsaturated fatty acids[13]
7Easy assimilation in Lactase deficient patientsL-lactate[14]
8Bone formationHigh level of calcium[15]
9DiarrheaHigh levels of sodium and potassium[16]
10Immuno enhancer and antimicrobial activityPeptidoglycan recognition protein (PRP)[17]
11Antibacterial and antiviral activityN-acetyl-glucosaminidase (NAGase)[18]
12Confers special passive immunityHeavy chain antibodies (HCAb) or variable heavy antibodies (VHH) or nanobodies[19]

Table 1.

Application of camel milk molecules in treatment of various diseases.

2.2 Commercial value of camel Milk

Latest reports suggest that the global camel dairy market reached 2.3 billion US$ in 2020. A total of 2.9 million tons of camel milk production has been recorded annually worldwide [24]. Camel dairy market is expected to reach USD 10.07 billion by 2027 growing at a growth rate of 8.0% in the forecast period 2020 to 2027.

Camel milk is traditionally consumed in either a raw form or in a fermented form. But to cater with preferences of urban populations now manufacturers have stated the production of novel camel milk based food products such as flavored beverages, sweets, chocolates and Ice creams. These products are becoming increasingly popular in nations such as UAE, Saudi Arabia,, Kazakhstan, Algeria, Australia, Morocco, Egypt and India. Its increasing demand has resulted in a wide opportunity for product innovation and generation of new markets. Camel milk products are relatively more expensive than other cattle dairy food items due to its high production costs. In spite of being low in fat, camel milk has a relatively high content of unsaturated fatty acids, which are beneficial for us. It’s suitable for lactose-intolerant people. Camel milk is actually considered a super food because of its high mineral and vitamin content. Moreover, its benefits for joint pain and diabetes has also been well documented. It’s no wonder then that it’s for long been consumed by the Bedouins (nomadic Arab people) and many other desert communities of the world to face their harsh living conditions.

The dairy market in India reached a value of 13,174 billion INR in 2021. In the coming times, International market analysis research and consulting (IMARC) group expects the market to reach 30,840 billion INR by 2027. This would amount to a compound annual growth rate (CAGR) of 14.98% during the time interval 2022–2027. Actually, despite its availability, India has been late in entering the market scenario. Only in the end of 2016 did the Food Safety and Standard Authority of India (FSSAI) decide the standards for commercialization of camel milk. Notably, while government dairy cooperatives have been slow to respond, some entrepreneurs, interestingly, even from the Raika community of Rajasthan, have taken multiple dynamic initiatives. India’s first camel milk brand Aadvik Foods is set to disrupt the dairy and organic milk products market. This New Delhi-based company started its journey in 2016 with just one liter of camel milk. Today, it is procuring around 10,000 liters a month, having sold over 2 lakhs liters over the last three-and-half years.

Advertisement

3. Clinical relevance of lactoferrin

Lactoferrin is a versatile molecule that has been molded by natural selection to be amongst the first line of defense in mammals [25]. As the second most abundant protein in colostrum, it is responsible for conferring immunity on newborns within the first few weeks of life [26]. Lactoferrin is involved in various physiological functions such as regulating homeostasis and cell proliferation, besides being a very potent antimicrobial agent. It has antibacterial, antifungal, antiviral, antioxidant, immunomodulatory, and anticancer activities [25, 27, 28, 29]. During infection and inflammation processes, the lactoferrin concentration increases through the recruitment of neutrophils. The important properties of lactoferrin have been depicted in the flow diagram in Figure 1.

Figure 1.

Bioactivity of lactoferrin.

Lactoferrin, the natural protein, is proving to be a highly promising bio-drug as an antimicrobial, immunomodulatory, and anticancer agent. According to Cragg et al., over 50% of the drugs in clinical trials for anticancer activity are isolated from natural sources or their ingredients. Several drugs currently used in chemotherapy are isolated from plant species and food sources [30, 31] Lactoferrin is a multi-functional protein with many beneficial properties. It is now recognized as a functional food for several products with commercial and clinical applications [32]. It is widely distributed in all biological fluids and is also expressed by immune cells, which release it under stimulation by pathogens.

The primary function of lactoferrin has been recognized to be in the modulation of the immune responses, besides iron transport, storage, and chelation. Lactoferrin activates immune cells and enhances their proliferation and differentiation. Its potential to perform multiple activities is often attributed to its capacity to bind iron and interact with diverse molecular and cellular components of hosts and pathogens. The multiple functions ascribed to lactoferrin can either be dependent or independent of lactoferrin’s iron-binding ability [33]. Furthermore, it is noteworthy that lactoferrin concentrations are locally elevated in inflammatory disorders such as neurodegenerative diseases, autoimmune diseases (e.g., arthritis), and allergic inflammation.

3.1 Lactoferrin as an Immuno-modulator

Lactoferrin is a cell-secreted mediator that bridges innate and adaptive immune responses. For immune-modulatory functions, it interacts with specific receptors of the target cells (either epithelial cells or cells of the immune system) It also can bind to bacterial cell wall LPS. Lactoferrin modulates the activation, proliferation, maturation, differentiation, and migration of immune cells. The functional modulations take place in the T and B cells, neutrophils, monocytes/macrophages, and dendritic cells belonging to the antigen-presenting class of cells. It acts via two mechanisms of intracellular signal transduction, i.e., nuclear factor kappa B and MAP kinase [34, 35, 36]. Furthermore, it affects the mechanisms of the innate response, by influencing the activation of the complement system, increasing the NK cell activity, increasing the phagocytic ability of monocytes, and by enhancing their cytotoxicity [37]. There are lactoferrin receptors on many immune cells, so lactoferrin directly affects how these cells function. Its action increases levels of cytokines such as tumor necrosis factor (TNF-alpha), interleukin 8 (IL-8), and Nitric Oxide production besides limiting pathogenic growth [37, 38].

Lactoferrin modulates innate and adaptive immune response because of its ability to bind LPS and CD-14. It also interferes with the formation of the CD14–LPS complex. This results in the attenuation of the LPS/CD-14/TLR-4, a signaling pathway involved in the pathogenesis of sepsis. Lactoferrin may stimulate the immune system by binding to CD-14 and then activating the TLR-4-mediated pathway while preventing overexpression of LPS-induced inflammation [39]. Lactoferrin, which functions as a natural iron scavenger and a modulator of signaling pathways, leads to the negative feedback of the inflammatory response. This is also shown by a decrease in the production of reactive oxygen species and various pro-inflammatory cytokines [40].

In addition to this, researchers have shown that in a murine model of diethyl nitrosamine-induced hepatocarcinogenesis, bovine milk lactoferrin significantly down-regulated the activity of liver antioxidant enzymes such as glutathione peroxidase, superoxide dismutase and catalase. It also increased the concentration of hepatic glutathione. Furthermore, bovine lactoferrin promoted the decrease of serum inflammatory markers and ameliorated in hepatic histological structures in a significant manner [41]. Furthermore, the applications of lactoferrin have been highlighted in Table 2.

S. NoApplicationsAdditional InformationReferences
1Antihypertensive activityObtained from lactoferrin-derived peptides[42]
2Protection from anemiaServes as an iron-containing protein useful for treatment[43]
3Bone regenerationBeneficial effect[44, 45]
4Prevention of metabolic diseasesEg. Obesity and diabetes[46]
5Acts as drug nanocarriersEmphasis on tumor-targeted drug delivery.[47]
6Protection from Neurodegenerative diseasesMarkedly increased expression upregulation in brain cells[48]
7Anti-inflammatory effectBy inhibition of the formation of hydroxyl free radicals.[49]
8DNA damage preventionPrevention of tumor formation in the central nervous system[50]
9Activates the p53 tumor suppressor gene (TSG)Suppression of tumor formation[50]
10Natural substitute for AntibioticsAntimicrobial activity: Also, a promising candidate to help break the vicious cycle of antibiotic resistance[49]
11Natural food preservativeAntimicrobial activity[49]

Table 2.

Applications of lactoferrin.

Other than the direct modulation of the immune response, lactoferrin strategically acts as a potent anti-inflammatory agent by scavenging ROS. Pro-oxidant agents can both promote DNA damage and induce as well as sustain inflammatory disorders. Inflammation itself drastically contributes to cancer development. Lactoferrin can maintain the physiological balance of ROS levels by direct binding of free iron, one of the principal actors involved in ROS production. It can also act as a regulator of key antioxidant enzymes, thus protecting the host from ROS-mediated cell and tissue damage in an overall manner [51].

The protective character of lactoferrin against cancer has been demonstrated, on numerous occasions, including its impact on chemically induced tumors, in laboratory rodents. Lactoferrin has even been reported to inhibit the development of experimental metastases in mice [52, 53, 54]. Lactoferrin-mediated inhibition of tumor growth might be related to apoptosis of these cells, induced by the activation of the Fas signaling pathway. Nevertheless, the exact mechanism of this function has not been discovered so far [55].

3.2 Camel milk lactoferrin as an antimicrobial, anticancer, and immunomodulatory agent

Lactoferrin is a highly conserved molecule. It possesses high degree of sequence homology and exerts multiple identical functions across mammalian species. Its ability to act as an antibacterial, antifungal, antiviral and antiparasitic, anti-inflammatory and immunomodulatory agent is shared amongst most mammalian species and has already been discussed [56, 57, 58]. More specifically, it inhibits growth of Escherichia coli, Klebsiella pneumonia, Clostridium, Helicobacter pylori, Staphylococcus aureus, Candida albicans, etc.

According to studies, the most therapeutic effects of camel milk are due to lactoferrin and immunoglobulins. Redwan & Tabll, 2007 reported that lactoferrin of camel milk has anti-viral activity and inhibits the virus entry into the cells. The camel milk lactoferrin stops HCV entry and replication in infected HepG2 cells two times higher than lactoferrin in human, bovine, and sheep milk. Generally, camel milk lactoferrin may directly interact with viral molecules or receptors (heparan sulfate) on the cell surface and prevent the virus’s attachment to the host cells and thus hinder infection. The virucidal mechanism of camel milk lactoferrin depends on its alpha-helical structure and cationic nature [59]. The antiviral effects of lactoferrin from camel milk have been demonstrated against many viruses. The mode of action behind this activity is the neutralization of virus particles and inhibition of their replication. Camel milk lactoferrin also has anti-pathogenic activity against human immunodeficiency virus, hepatitis B and C, cytomegalovirus as well as herpes simplex virus-1 infection. Not only this, but camel lactoferrin’s immunomodulatory role is exemplified by the fact that it modulates the activation and maturation of various immune cells such as neutrophils, macrophages, and lymphocytes [60].

An earlier study on camel milk lactoferrin has demonstrated the ability to inhibit the growth of colon cancer cells line HCT-116. Camel milk lactoferrin exerted antioxidant activity through scavenging NO and the DPPH free radical. It has shown the capability to furnish reducing power as evident by total antioxidant assays. Camel milk lactoferrin also inhibited DNA damage most likely through binding catalytic iron [5].

Camel milk lactoferrin exhibits an anti-inflammatory activity against IL-1β induced activation of osteoarthritis associated chondrocytes in humans by blocking the NF- kappa B mediated signaling. Furthermore it inhibited cyclooxygenase-2 expression and PGE2 production in stimulated osteoarthritis chondrocytes. N. Rasheed et al., 2016 have reported that camel lactoferrin has cartilage protective and anti-arthritic activity. This novel mode of action of camel milk lactoferrin is very important in understanding the mechanisms behind its anti-inflammatory or anti-arthritic effects [61]. The above studies on lactoferrin derived from camel milk highlight the clinical relevance.

3.3 Anticancer potential of lactoferrin from other mammalian species

Human and Bovine lactoferrin has been suggested to be able to act in tumor prevention and treatment [62, 63]. The lactoferrin preventive effect has been demonstrated in several animal models bearing different types of malignancies, including lung, tongue, esophagus, liver, and colorectal tumors [64, 65, 66, 67]. Whereas lactoferrin treatment, was found to be effective in inhibiting growth, metastasis, and tumor-associated angiogenesis [63, 68, 69].

Bovine lactoferrin prevents development of chemically induced tumors. This effect has been confirmed in studies conducted on laboratory rodents. Based on in vivo studies, oral administration of lactoferrin to rodents significantly decreased the chemically induced carcinogenesis in various organs such as breast, esophagus, tongue, lung, liver, colon, and bladder. It also hindered angiogenesis and decreased the incidence of metastases in experimental mice [67].

Furthermore, the combined administration of Lactoferrin and temozolomide enhances the effect of chemotherapy both in vitro and in vivo [55] Similarly, humans suffering from lung cancer undergoing chemotherapy had increased immune system response after taking human lactoferrin post-treatment [70].

Lactoferrin from a bovine source is a promising candidate as an anticancer agent [71] Although bovine milk contains lactoferrin, the human form has been found to be far more potent. Animal studies with mice or rats have shown beneficial effects of bovine lactoferrin ingestion as it can inhibit carcinogen–induced tumors in the colon, esophagus, lung, tongue, bladder, and liver [72].

The anticancer effect of lactoferrin has been extensively studied, and it has been observed that in the presence of Lactoferrin, cancer cells suffer significant damage. It is known to cause cell cycle arrest, damage to the cytoskeleton, and induction of apoptosis, in addition to decreasing cell migration [63, 73]. It decreased the viability and growth of breast cancer cell lines (HS578T and T47D). It also stopped cancer cell growth during the cell cycle and disrupted the cancer cell membrane [74]. Bovine lactoferrin efficiently inhibited the growth of breast cancer cells, suggesting that it has a potential to act as an anti-cancer agent against breast cancer [63, 75].

Lactoferrin helps to prevent the growth of cancer cells and shrinks the cancer cells. It is also known for its inhibitory action on cancer cell proliferation and its anti-inflammatory as well as antioxidant abilities against them [75]. Lactoferrin expression levels are decreased in colorectal cancer as compared with normal tissue. Lactoferrin knockout mice demonstrated a great susceptibility to inflammation-induced colorectal dysplasia. Treatment of knockout mice with lactoferrin post-chemotherapy accelerated the reconstitution of the immune system, reducing the chances for infection, following chemotherapy treatment. Additionally, lactoferrin is significantly downregulated in specimens of nasopharyngeal carcinoma (NPC) and is negatively associated with tumor progression, metastasis, and prognosis of patients with NPC [76].

Lactoferrin was shown to have preventive effects against gastrointestinal cancers, such as cancer of the colon, stomach, liver, and pancreas, and against metastasis of such neoplasms [77, 78]. Xu et al. (2010) demonstrated that bovine lactoferrin induces apoptosis in stomach cancer, thereby suppressing it [79]. Oral administration of lactoferrin decreased the occurrence of colon cancer by 83%. The number of adenocarcinoma cells in the gut of rats was reduced after the ingestion of lactoferrin.

Lactoferrin-mediated inhibition of tumor growth might be related to apoptosis of these cells, induced by the activation of the Fas signaling pathway [55]. It has been suggested that the treatment of lactoferrin knockout mice with lactoferrin (post-chemotherapy) accelerated the reconstitution of the immune system. This also reduced the chances of infection following chemotherapy treatment [76]. Lactoferrin can scavenge free iron in fluids and inflamed and infected sites, suppressing free radical-mediated damage and decreasing the availability of the metal to pathogens and cancer cells. Also, lactoferrin hinders migration in a model of human glioblastoma by reverting an epithelial-to-mesenchymal transition-like process [4, 32].

3.4 Lactoferrin in COVID-19 treatment

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has recently become a primary global health concern, leading to the urgent development of therapeutic agents for its prevention and treatment. Iron overload is understood to have an important role in the pathogenesis of COVID-19. Actually some features (such as inflammation hyperferritinemia, hypercoagulation, and immune dysfunction) manifested a in COVID-19, are linked to iron overload. The presence of free iron, resulting from iron overload and dysregulation, is very highly reactive and toxic due to its reactive oxygen species (ROS) generation potential. The ROS produced react with very important cellular biomolecules and induce their subsequent damage. Nucleic acids, proteins as well as membranous and cellular lipids are effected by the highly activate inflammatory processes which may be either acute or chronic. The linkage of inflammation with multiple clinical conditions, such as cancer is well understood [80]. Lactoferrin has exhibited unique immunomodulatory, anti-inflammatory, and broad-spectrum antiviral activity indicating its potential for the cure of COVID-19 cases and prevention of its devastating effects on multiple target organs [81, 82]. Lactoferrin could counteract the coronavirus infection and inflammation, acting either as a natural barrier of respiratory and intestinal mucosa or reverting the iron disorders related to the viral colonization. Iron-catalyzed lipid damage is understood to exerts a direct effect on ferroptosis, the newly discovered cell death mechanism. Unlike programmed cell death (PCD), ferroptosis not only leads to amplified cell death but is also associated with inflammation. Iron chelators are generally recognized as safe and have been shown to protect patients in diseases characterized by iron overload. Research work also suggests that iron chelators exhibit antimicrobial activities. It is suggested that the naturally occurring iron chelators, such as lactoferrin, exert anti-inflammatory as well as immunomodulatory effects. It binds to some of the same receptors used by coronaviruses and hence blocks its entry into host cells. Iron chelators may actually be of a very high therapeutic value during the present scenario of the ongoing COVID-19 pandemic [80]. Therefore, the use of lactoferrin may be of value in the prevention and management of COVID-19. The use of lactoferrin appears to be a promising approach to treating COVID-19, but further investigations are required to verify its antiviral activity in vitro and in vivo [83, 84, 85].

3.5 Lactoferrin assimilation in vivo

Lactoferrin shows high bioavailability after oral administration, high selectivity toward cancer cells, and a wide range of molecular targets controlling tumor proliferation, survival, migration, invasion, and metastasis. Notably, lactoferrin may either promote or inhibit cell proliferation and migration depending on whether its target cell is normal or cancerous. Significantly, its administration is well tolerated and does not exhibit any significant side effects. Furthermore, lactoferrin may prevent cancer development and growth by enhancing the adaptive immune response. Oral administration of lactoferrin has also led to promising improvement in the immune responses of antiretroviral therapy in naıve children suffering from HIV [86]. Oral administration of lactoferrin decreased the occurrence of colon cancer by 83%, while the quantity of adenocarcinoma cells was reduced in the gut of rats after ingestion of Lactoferrin, ameliorating tongue cancer.

Of particular interest is the notion that even its oral administration may be effective. This is different from many other therapeutic proteins, which typically require other invasive routes of administration [87]. Oral administration of bovine lactoferrin prevents carcinogenesis in the colon and other organs in rats. It also inhibits lung metastasis in mice. It might be mediating its anti-carcinogenesis effects is by increasing expression of relevant cytokines and inducing subsequent activation of immune cells [67]. It interacts with a wide range of molecular targets controlling tumor proliferation, survival, migration, invasion, and metastasis. It may be noted that lactoferrin can promote or inhibit cell proliferation and migration depending on whether it acts upon normal or cancerous cells, respectively. Moreover, lactoferrin can prevent the development or inhibit cancer growth by boosting adaptive immune response. Most importantly, lactoferrin administration is highly tolerated and does not present significant adverse effects.

Oral administration of lactoferrin is the most widely adopted method of its delivery into the human body. This still possesses some challenges that must be addressed before reaping the highest benefit from its intake. Since the functional domains of lactoferrin are highly dependent on its unique 3D structural conformation, the gastrointestinal breakdown of lactoferrin may cause undesirable loss of some of its functional properties. The important receptors of lactoferrin are located at the intestinal mucosa and lymphatic tissue cells in the gut [88, 89, 90, 91]. Hence, the delivery of lactoferrin through oral administration requires that it is protected so that it passes through the stomach and is delivered to the absorption sites in a functionally active form. But the most important thing is to note that the digestive tract in infants and newborns is not mature enough (e.g., the intragastric pH and the gastric emptying rate are higher than in adults), and lactoferrin would not be completely digested under these conditions. This hypothesis has been confirmed by measuring the unhydrolyzed lactoferrin in fecal extracts of babies [92, 93]. Nevertheless, the degradation of lactoferrin during the gastrointestinal tract could also be beneficial. It has been reported that strong antibacterial peptides such as lactoferricin and lactoferrampin are produced by its pepsin hydrolysis [94, 95]. This further benefits the utilization of lactoferrin in high value food products such as infant formula, nutritional supplements, and other formulations that aim at delivering lactoferrin through oral administration.

A commonly accepted method to protect lactoferrin during digestion is microencapsulation. In this method, a protective matrix is created around the lactoferrin core. Food grade proteins (e.g., bovine serum albumin, β- lactoglobulin) and polysaccharides (e.g., pectin, carrageenan, sodium alginate, gum Arabic) are commonly used as the shell materials. This core-shell structure excellently protects lactoferrin from the harsh environment prevailing in the human digestive system. The microencapsulation also helps achieve targeted and controlled release of lactoferrin by simply using shell materials with suitable properties.

Based on in vivo studies, oral administration of lactoferrin to rodents significantly decreased the chemically induced carcinogenesis in various organs such as the breast, esophagus, tongue, lung, liver, colon, bladder, and hindered angiogenesis [78]. During the past two decades, many animal and human studies have proved that orally administered Lactoferrin exerts many beneficial effects on the health of animals and humans [75].

3.6 Lactoferrin industries in the world

Human and bovine lactoferrin is generally recognized as a safe substance (GRAS) by the Food and Drug Administration (FDA, USA). Some pharmaceutical industries (e.g., Morinaga Milk Industry Co LTD Venture LLC, Ventria Bioscience, AusBioMed, Biopharming, Max Biocare, etc.) are into commercialization of human and bovine Lactoferrin related products such as nutraceuticals and vitamin supplements for pediatric use. Also are being produced baby foods, beverages, and a cell growth promoting adjuncts for better child development.

According to Global Market Insights Inc. report, the global lactoferrin powder revenue size was US$195 million (€164 m) in 2020, which is set to surpass US$315 million (€364.1 m) by 2027 and is expected to register over 7.7% CAGR between 2021 and 2027. Owing to the anti-inflammatory attribute of lactoferrin its market is likely to surpass 70 Million USD by 2027. Its antiviral efficacy is being increasingly recognized during the COVID-19 pandemic. Furthermore, its immunomodulatory and anti-inflammatory capability is expected to raise product demand in an unprecedented manner from the pharmaceutical sector. It is estimated that the lactoferrin industry from the pharmaceutical application would actually exceed 53.78 Million USD by 2027. The global Lactoferrin Market is anticipated to attain substantial growth by the end of the forecast period (2021–2025).

Lactoferrin has also been used in different products, such as probiotics, supplemental tablets, cosmetics, and as a natural solubilizer of iron in food. It is also used in the treatment of diverse carcinomas, severe sepsis, and diabetic foot ulcers. Numerous attributes of lactoferrin, such as its iron absorption ability, antibacterial, anti-inflammatory, antioxidant, and immunity-boosting capabilities, are likely to provide promising opportunities for the lactoferrin industry. The ability of lactoferrin to prevent biofilm formation helps inhibiting the growth of bacteria. This can lead to an enhanced product demand owing to its therapeutic applications. The higher susceptibility of infections in infants and newborns due to an underdeveloped immune system can be supplemented by the lactoferrin industry. Growing demand for lactoferrin from physical fitness and sports nutrition application is likely to drive the growth of lactoferrin capsules during the forecast period. Increasing instances of digestive and gastric disorders should boost the demand for lactoferrin as an anti-inflammatory ingredient.

Advertisement

4. Conclusion

Lactoferrin, a multifunctional ingredient amply found in camel milk. It has numerous applications as a natural antimicrobial food additive and pharmaceutical agent. Camel milk lactoferrin has unique antimicrobial, antioxidant, anti-infective and anti-cancer activity. It can be used as a natural alternative to chemical antibiotics. Camel milk also been suggested for weight management. Lactoferrin from the milk of different indigenous species is being increasingly used as a specialty ingredient in the dairy industry. Lactoferrin can be used for biopreservation of foods such as milk, meat, fresh-cut fruits and vegetables, and their products to increase shelf life, control diseases and enhance public health. Indeed, our feeling is that camel milk lactoferrin can be used in synergy with both, conventional therapies and recent advancements allowing many therapeutic agents with potential side effect to be administered at lower, more sustainable doses.

Advertisement

Acknowledgments

The authors would like to acknowledge the Birla Institute of Technology and Science, Pilani (BITS Pilani), Pilani Campus, Rajasthan for the infrastructure support. NM would like to thank the Department of Science and Technology (DST), India for the Innovation in Science Pursuit for Inspired Research [INSPIRE] fellowship [DST/INSPIRE Fellowship/2016/IF160137].

Advertisement

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1. El-Hatmi H, Girardet JM, Gaillard JL, et al. Characterisation of whey proteins of camel (Camelus dromedarius) milk and colostrum. Small Ruminant Research. 2007;70:267-271
  2. 2. Ebrahim F, Fellah A, Eldarhobi S, et al. Purification of lactoferrin from camel colostrum and protein profiles of camel and bovine Milk. Alexendar Journal of Veterinary Science. 2019;60:67
  3. 3. El-F Fakharany EM, Tabll A, Abd A, et al. Potential activity of camel milk-amylase and lactoferrin against Hepatitis C virus infectivity in Hepg2 and lymphocytes. 2008;8:101-109
  4. 4. Cutone A, Colella B, Pagliaro A, et al. Native and iron-saturated bovine lactoferrin differently hinder migration in a model of human glioblastoma by reverting epithelial-to-mesenchymal transition-like process and inhibiting interleukin-6/STAT3 axis. Cellular Signalling. 2020;65:109461
  5. 5. Habib HM, Ibrahim WH, Schneider-Stock R, et al. Camel milk lactoferrin reduces the proliferation of colorectal cancer cells and exerts antioxidant and DNA damage inhibitory activities. Food Chemistry. 2013;141:148-152
  6. 6. Dubey U, Lal M, Mittal A, et al. Therapeutic potential of camel Milk. Emirates Journal of Food Agriculture. 2016;28:164
  7. 7. Agrawal RP, Tantia P, Jain S, et al. Camel milk: A possible boon for type 1 diabetic patients. Cellular and Molecular Biology. 2013;59:99-107
  8. 8. El-Agamy EI, Nawar M, Shamsia SM, et al. Are camel milk proteins convenient to the nutrition of cow milk allergic children? Small Ruminant Research. 2009;82:1-6
  9. 9. Hamad EM, Abdel-Rahi EA, Romeih EA. Beneficial effect of camel Milk on liver and kidneys function in diabetic Sprague-Dawley rats. International Journal of Dairy Science. 2011;6:190-197
  10. 10. Faye B, Bengoumi M, Al-Masaud A, et al. Comparative milk and serum cholesterol content in dairy cow and camel. Journal of King Saudi University Science. 2015;27:168-175
  11. 11. Agamy ES, Ruppanner R, Ismail A, et al. Antibacterial and antiviral activity of camel milk protective proteins. Journal of Dairy Research. 1992;59:169-175
  12. 12. Konuspayeva G, Faye B, Loiseau G, et al. Lactoferrin and immunoglobulin contents in camel’s milk (Camelus bactrianus, campus dromedarius, and hybrids) from Kazakhstan. Journal of Dairy Science. 2007;90:38-46
  13. 13. Konuspayeva G, Faye B, Loiseau G. et al, The composition of camel milk: A meta-analysis of the literature data. Journal of Food Composition and Analysis. 2009;22(2):95-101. DOI: 10.1016/j.jfca.2008.09.008
  14. 14. Kaskous S. Importance of camel milk for human health. Emirates Journal of Food Agriculture. 2016;28:158-163
  15. 15. Davicco MJ, Barlet JP, Davicco MJ, et al. Influence of 1α-hydroxycholecalciferol on calcium and phosphorus concentration in camel milk. Journal of Dairy Research. 1994;61:567-571
  16. 16. Yagil DVM. Camel milk and its unique anti-diarrheal Properties. 15, http://www.crohnscanada.org, [Accessed May 26, 2022]
  17. 17. EI el A, R R, A I et al. Antibacterial and antiviral activity of camel milk protective proteins. The Journal of Dairy Research. 1992;59:169-175
  18. 18. Galali Y, Al-Dmoor HM. Journal of family medicine and disease prevention miraculous properties of camel Milk and perspective of modern science. Journal of Family Medicine and Disease Prevention. 2019;5:95
  19. 19. Muyldermans S. Nanobodies: Natural single-domain antibodies. Annual Review of Biochemistry. 2013;82:775-797
  20. 20. Korashy HM, el Gendy MAM, Alhaider AA, et al. Camel milk modulates the expression of aryl hydrocarbon receptor-regulated genes, Cyp1a1, Nqo1, and Gsta1, in murine hepatoma Hepa 1c1c7 cells. Journal of Biomedicine Biotechnology. 2012:782642
  21. 21. Haddadin MSY, Gammoh SI, Robinson RK. Seasonal variations in the chemical composition of camel milk in Jordan. The Journal of Dairy Research. 2008;75:8-12
  22. 22. Alhaider AA, Abdel Gader AGM, Almeshaal N, et al. Camel milk inhibits inflammatory angiogenesis via downregulation of proangiogenic and proinflammatory cytokines in mice. APMIS. 2014;122:599-607
  23. 23. Mittal A, Mahala N, Krishna KV, et al. Calcium chloride linked camel milk derived casein nanoparticles for the delivery of sorafenib in hepatocarcinoma cells. BIOCELL. 2021;46(1):127-136
  24. 24. Hailu Y, Hansen EB, Seifu E, et al. Functional and technological properties of camel milk proteins: A review. Journal of Dairy Research. 2016;83:422-429
  25. 25. Siqueiros-Cendón T, Arévalo-Gallegos S, Iglesias-Figueroa BF, et al. Immunomodulatory effects of lactoferrin. Acta Pharmacologica Sinica. 2014;35:557-566
  26. 26. Turin CG, Ochoa TJ. The role of maternal breast Milk in preventing infantile Diarrhea in the developing world. Current Tropical Medical Report. 2014;1:97-105
  27. 27. Baker EN, Baker HM. Molecular structure, binding properties and dynamics of lactoferrin. Cellular and Molecular Life Sciences. 2005;62:2531-2539
  28. 28. Kanyshkova TG, Buneva VN, Nevinsky GA. Lactoferrin and its biological functions. Biochemistry (Mosc). 2001;66:1-7
  29. 29. Lönnerdal B, Iyer S. Lactoferrin: Molecular structure and biological function. Annual Review of Nutrition. 1995;15:93-110
  30. 30. Cragg GM, Schepartz SA, Suffness M, et al. The taxol supply crisis. New NCI policies for handling the large-scale production of novel natural product anticancer and anti-HIV agents. Journal of Natural Products. 1993;56:1657-1668
  31. 31. Samarghandian S, Shabestari MM. DNA fragmentation and apoptosis induced by safranal in human prostate cancer cell line. Indian Journal of Urology. 2013;29:177-183
  32. 32. Adlerova L, Bartoskova A, Faldyna M. Lactoferrin: A review. Veterinary Medicine (Praha). 2008;53:457-468
  33. 33. Rosa L, Cutone A, Lepanto MS, et al. Lactoferrin: A natural glycoprotein involved in iron and inflammatory homeostasis. International Journal of Molecular Science. 2017;18:22
  34. 34. Dashper SG, Pan Y, Veith PD, et al. Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity. Antimicrobial Agents and Chemotherapy. 2012;56:1548
  35. 35. Gibbons JA, Kanwar JR, Kanwar RK. Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer. BMC Cancer. 2015;15:1-16
  36. 36. Kawai K, Shimazaki K, Higuchi H, et al. Antibacterial activity of bovine lactoferrin hydrolysate against mastitis pathogens and its effect on superoxide production of bovine neutrophils. Zoonoses and Public Health. 2007;54:160-164
  37. 37. Actor J, Hwang S-A, Kruzel M. Lactoferrin as a natural immune modulator. Current Pharmaceutical Design. 2009;15:1956-1973
  38. 38. Majka G, Więcek G, Śróttek M, et al. The impact of lactoferrin with different levels of metal saturation on the intestinal epithelial barrier function and mucosal inflammation. Biometals. 2016;29:1019
  39. 39. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42:145-151
  40. 40. Kruzel ML, Bacsi A, Choudhury B, et al. Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology. 2006;119:159-166
  41. 41. Mohammed MM, Ramadan G, Zoheiry MK, et al. Antihepatocarcinogenic activity of whey protein concentrate and lactoferrin in diethylnitrosamine-treated male albino mice. Environmental Toxicology. 2019;34:1025-1033
  42. 42. Fernández-Musoles R, Castelló-Ruiz M, Arce C, et al. Antihypertensive mechanism of lactoferrin-derived peptides: Angiotensin receptor blocking effect. Journal of Agricultural and Food Chemistry. 2014;62:173-181
  43. 43. Artym J, Zimecki M, Kruzel ML. Lactoferrin for prevention and treatment of anemia and inflammation in pregnant women: A comprehensive review. Biomedicines. 2021;9
  44. 44. Li W, Zhu S, Hu J. Bone regeneration is promoted by orally administered bovine lactoferrin in a rabbit tibial distraction osteogenesis model. Clinical Orthopaedics and Related Research. 2015;473:2383-2393
  45. 45. Gao R, Watson M, Callon KE, et al. Local application of lactoferrin promotes bone regeneration in a rat critical-sized calvarial defect model as demonstrated by micro-CT and histological analysis. Journal of Tissue Engineering and Regenerative Medicine. 2018;12:e620-e626
  46. 46. Sun J, Ren F, Xiong L, et al. Bovine lactoferrin suppresses high-fat diet induced obesity and modulates gut microbiota in C57BL/6J mice. Journal of Functional Foods. 2016;22:189-200
  47. 47. Elzoghby AO, Abdelmoneem MA, Hassanin IA, et al. Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand. Biomaterials. 2020;263
  48. 48. Li YQ , Guo C. A review on lactoferrin and central nervous system diseases. Cell. 2021;10
  49. 49. Kell DB, Heyden EL, Pretorius E. The biology of lactoferrin, an Iron-binding protein that can help defend against viruses and Bacteria. Frontiers in Immunology. 2020;11:1221
  50. 50. Pan S, Weng H, Hu G, et al. Lactoferrin may inhibit the development of cancer via its immunostimulatory and immunomodulatory activities (review). International Journal of Oncology. 2021;59:1-11
  51. 51. Kruzel ML, Zimecki M, Actor JK. Lactoferrin in a context of inflammation-induced pathology. Frontiers in Immunology. 2017;8:1438
  52. 52. Wolf JS, Li D, Taylor RJ, et al. Lactoferrin inhibits growth of malignant tumors of the head and neck. ORL: Journal for Otorhinolaryngology and Its Related Specialties. 2003;65:245-249
  53. 53. Bezault J, Bhimani R, Wiprovnick J, et al. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. AACR, 1994. https://cancerres.aacrjournals.org/content/54/9/2310.short. [Accessed March 5, 2022]
  54. 54. Wang WP, Iigo M, Sato J, et al. Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Japanese Journal of Cancer Research. 2000;91:1022-1027
  55. 55. Fujita KI, Matsuda E, Sekine K, et al. Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis. 2004;25:1961-1966
  56. 56. Puddu P, Latorre D, Carollo M, et al. Bovine lactoferrin counteracts toll-like receptor mediated activation signals in antigen presenting cells. PLoS One. 2011;6:22504
  57. 57. Puddu P, Valenti P, Gessani S. Immunomodulatory effects of lactoferrin on antigen presenting cells. Biochimie. 2009;91:11-18
  58. 58. Valenti P, Antonini G. Lactoferrin: An important host defence against microbial and viral attack. Cellular and Molecular Life Sciences. 2005;62:2576-2587
  59. 59. Redwan ERM, Tabll A. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes. Journal of Immunoassay & Immunochemistry. 2007;28:267-277
  60. 60. Rasheed Z. Medicinal values of bioactive constituents of camel milk: A concise report. International Journal of Health Science (Qassim). 2017;11:1
  61. 61. Rasheed N, Alghasham A, Rasheed Z. Lactoferrin from Camelus dromedarius inhibits nuclear transcription factor-kappa B activation, Cyclooxygenase-2 expression and prostaglandin E2 production in stimulated human chondrocytes, 2016
  62. 62. Tsuda H, Kozu T, Iinuma G, et al. Cancer prevention by bovine lactoferrin: From animal studies to human trial. Biometals. 2010;23:399-409
  63. 63. Zhang Y, Lima CF, Rodrigues LR. Anticancer effects of lactoferrin: Underlying mechanisms and future trends in cancer therapy. Nutrition Reviews. 2014;72:763-773
  64. 64. Hegazy RR, Mansour DF, Salama AA, et al. Regulation of PKB/Akt-pathway in the chemopreventive effect of lactoferrin against diethylnitrosamine-induced hepatocarcinogenesis in rats. Pharmacological Reports. 2019;71:879-891
  65. 65. Sugihara Y, Zuo X, Takata T, et al. Inhibition of DMH-DSS-induced colorectal cancer by liposomal bovine lactoferrin in rats. Oncology Letters. 2017;14:5688-5694
  66. 66. Tanaka T, Kawabata K, Kohno H, et al. Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Japanese Journal of Cancer Research. 2000;91:25-33
  67. 67. Ushida Y, Sekine K, Kuhara T, et al. Possible Chemopreventive effects of bovine lactoferrin on Esophagus and lung carcinogenesis in the rat. Japanese Journal of Cancer Research. 1999;90:262-267
  68. 68. Shimamura M, Yamamoto Y, Ashino H, et al. Bovine lactoferrin inhibits tumor-induced angiogenesis. International Journal of Cancer. 2004;111:111-116
  69. 69. Gibbons JA, Kanwar RK, Kanwar JR. Lactoferrin and cancer in different cancer models. Frontiers in Bioscience-Scholar. 2011;3:1080-1088
  70. 70. Madan RA, Tsang K-Y, Bilusic M, et al. Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancer. The Oncologist. 2013;18:821-822
  71. 71. Kanwar JR, Roy K, Patel Y, et al. Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions. Molecules. 2015;20:9703-9731
  72. 72. Kozu T, Iinuma G, Ohashi Y, et al. Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prevention Research. 2009;2:975-983
  73. 73. de Mejia EG, Dia VP. The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells. Cancer and Metastasis Reviews. 2010;29:511-528
  74. 74. Chandra Mohan KVP, Kumaraguruparan R, Prathiba D, et al. Modulation of xenobiotic-metabolizing enzymes and redox status during chemoprevention of hamster buccal carcinogenesis by bovine lactoferrin. Nutrition. 2006;22:940-946
  75. 75. Duarte DC, Nicolau A, Teixeira JA, et al. The effect of bovine milk lactoferrin on human breast cancer cell lines. Journal of Dairy Science. 2011;94:66-76
  76. 76. Ye Q , Zheng Y, Fan S, et al. Lactoferrin deficiency promotes colitis-associated colorectal dysplasia in mice. PLoS One. 2014;9
  77. 77. Tsuda H, Sekine K, Fujita KI, et al. Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies. Biochemistry and Cell Biology. 2002;80:131-136
  78. 78. Iigo M, Alexander DB, Long N, et al. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine. Biochimie. 2009;91:86-101
  79. 79. Xu XX, Jiang HR, Li HB, et al. Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin. Journal of Dairy Science. 2010;93:2344-2350
  80. 80. Habib HM, Ibrahim S, Zaim A, et al. The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomedicine and Pharmacotherapy. 2021;136:11228
  81. 81. Legrand D, Elass E, Carpentier M, et al. Lactoferrin: A modulator of immune and inflammatory responses. Cellular and Molecular Life Sciences. 2005;62:2549-2559
  82. 82. Berlutti F, Pantanella F, Natalizi T, et al. Antiviral properties of lactoferrin--a natural immunity molecule. Molecules. 2011;16:6992-7012
  83. 83. Salaris C, Scarpa M, Elli M, et al. Protective effects of lactoferrin against SARS-CoV-2 infection in vitro. Nutrients. 2021;13:328
  84. 84. Wang Y, Wang P, Wang H, et al. Lactoferrin for the treatment of COVID-19 (review). Experimental and Therapeutic Medicine. 2020;20:1-1
  85. 85. Morniroli D, Consales A, Crippa BL, et al. The antiviral properties of human milk: A multitude of defence tools from mother nature. Nutrients. 2021;13:694
  86. 86. Zuccotti GV, Vigano A, Borelli M, et al. Modulation of innate and adaptive immunity by lactoferrin in human immunodeficiency virus (HIV)-infected, antiretroviral therapy-naïve children. International Journal of Antimicrobial Agents. 2007;29:353-355
  87. 87. Leader B, Baca QJ, Golan DE. Protein therapeutics: A summary and pharmacological classification. Nature Reviews Drug Discovery. 2007;7:21-39
  88. 88. Yao X, Bunt C, Cornish J, et al. Oral delivery of bovine lactoferrin using pectin- and chitosan-modified liposomes and solid lipid particles: Improvement of stability of lactoferrin. Chemical Biology & Drug Design. 2015;86:466-475
  89. 89. Yamano E, Miyauchi M, Furusyo H, et al. Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis. Laboratory Investigation. 2010;90:1236-1246
  90. 90. Takeuchi T, Jyonotsuka T, Kamemori N, Kawano G, Shimizu H, Ando K et al. Enteric-formulated lactoferrin was more effectively transported into blood circulation from gastrointestinal tract in adult rats. Experimental Physiology. 2006;91:139-145
  91. 91. Jiang R, Lopez V, Kelleher SL, et al. Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERK-signaling and cell proliferation in Caco-2 cells. Journal of Cellular Physiology. 2011;226:3022-3031
  92. 92. Gisbert JP, McNicholl AG, Gomollon F. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflammatory Bowel Diseases. 2009;15:1746-1754
  93. 93. Spik G, Coddeville B, Mazurier J, et al. Primary and three-dimensional structure of lactotransferrin (lactoferrin) glycans. Advances in Experimental Medicine and Biology. 1994;357:21-32
  94. 94. Lizzi AR, Carnicelli V, Clarkson MM, et al. Bovine lactoferrin and its tryptic peptides: Antibacterial activity against different species. Applied Biochemistry and Microbiology. 2016;52:435-440
  95. 95. Bellamy W, Takase M, Yamauchi K, et al. Identification of the bactericidal domain of lactoferrin. Biochimica et Biophysica Acta. 1992;1121:130-136

Written By

Neelam Mahala, Aastha Mittal and Uma S. Dubey

Submitted: 17 September 2022 Reviewed: 27 September 2022 Published: 07 November 2022